Introducing the Anti-ANDV Glycoprotein Recombinant Antibody (SAA3002), a powerful tool for researchers in the biotech industry. This cutting-edge antibody is specifically designed to target the glycoprotein of the Andes virus (ANDV), a deadly pathogen responsible for causing hantavirus pulmonary syndrome (HPS).
The biological function of this antibody is to bind to the ANDV glycoprotein, preventing it from infecting cells and replicating. This makes it a valuable tool for studying the virus and developing potential treatments. Additionally, the antibody can be used in diagnostic assays to detect the presence of ANDV in patient samples.
The main applications of the Anti-ANDV Glycoprotein Recombinant Antibody (SAA3002) include research in virology, immunology, and infectious diseases. It is particularly useful for studying the pathogenesis of ANDV and developing antiviral therapies. This antibody can also aid in the development of diagnostic tests for HPS, as well as serve as a potential treatment option for those infected with ANDV.
In experimental use cases, the Anti-ANDV Glycoprotein Recombinant Antibody (SAA3002) has shown promising results. In one study, it was able to neutralize ANDV and prevent infection in vitro. Another study demonstrated its potential for use in immunotherapy, as it was able to protect mice from lethal doses of ANDV.
With its high specificity and potency, the Anti-ANDV Glycoprotein Recombinant Antibody (SAA3002) is a valuable addition to any research project focused on ANDV or HPS. Don’t miss out on the opportunity to advance your research with this innovative antibody. Order now and take the first step towards unlocking the mysteries of the deadly Andes virus.
There are no reviews yet.